awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47115888-4E22A291-DE55-443F-A615-0F0297AD888A
Q47115888-4E22A291-DE55-443F-A615-0F0297AD888A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47115888-4E22A291-DE55-443F-A615-0F0297AD888A
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report.
P2860
Q47115888-4E22A291-DE55-443F-A615-0F0297AD888A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47115888-4E22A291-DE55-443F-A615-0F0297AD888A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c8b43929abbe408a38d7f93dcb679e4ac42c92b
P2860
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.